SKU(재고 관리 코드):PAA306Hu01
Polyclonal Antibody to Cathepsin L (CTSL)
Polyclonal Antibody to Cathepsin L (CTSL)
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.
Product No.
PAA306Hu01
Organism Species
Homo sapiens (Human).
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPA306Hu01-Recombinant Cathepsin L (CTSL)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.5mg/ml
Organism Species More
Mus musculus (Mouse)
Applications
WB,IHC
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against CTSL. It has been selected for its ability to recognize CTSL in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Magazine | Citations |
Hypertension | Identification of Cathepsin L as a Potential Sex-Specific Biomarker for Renal Damage. Ahajournals: source |
The Journal of International Medical Research | Plasma Cathepsin L and Its Related Pro/Antiangiogenic Factors Play Useful Roles in Predicting Rich Coronary Collaterals in Patients with Coronary Heart Disease Ingenta: art00021 |
Atherosclerosis.? | Biochemical and clinical correlation of intraplaque neovascularization using contrast-enhanced ultrasound of the carotid artery Pubmed:24534452 |
International Journal of Molecular Sciences | A New Analytical Method for Determination of Cathepsin L Based on the Surface Plasmon Resonance Imaging Biosensor Pubmed: 31052424 |
EMBO Molecular Medicine | Immune‐mediated ECM depletion improves tumour perfusion and payload delivery Pubmed: 31709774 |
Cardiovasc Res | Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size 34132807 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPA306Hu01 | Recombinant Cathepsin L (CTSL) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA306Hu01 | Polyclonal Antibody to Cathepsin L (CTSL) | WB,IHC |
LAA306Hu71 | Biotin-Linked Polyclonal Antibody to Cathepsin L (CTSL) | WB; IHC; ICC. |
MAA306Hu22 | Monoclonal Antibody to Cathepsin L (CTSL) | WB; IHC; ICC; IP. |
SEA306Hu | ELISA Kit for Cathepsin L (CTSL) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA306Hu | Magnetic Luminex Assay Kit for Cathepsin L (CTSL) ,etc. | Magnetic Luminex Assay for Antigen Detection. |